1. Home
  2. BHB vs ADCT Comparison

BHB vs ADCT Comparison

Compare BHB & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bar Harbor Bankshares Inc.

BHB

Bar Harbor Bankshares Inc.

HOLD

Current Price

$32.16

Market Cap

527.8M

Sector

Finance

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$4.08

Market Cap

484.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHB
ADCT
Founded
1887
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
527.8M
484.4M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
BHB
ADCT
Price
$32.16
$4.08
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$36.67
$7.75
AVG Volume (30 Days)
167.4K
757.8K
Earning Date
04-16-2026
03-10-2026
Dividend Yield
3.99%
N/A
EPS Growth
N/A
30.86
EPS
2.31
N/A
Revenue
N/A
$81,357,000.00
Revenue This Year
$22.68
N/A
Revenue Next Year
$3.66
$68.29
P/E Ratio
$13.93
N/A
Revenue Growth
N/A
14.85
52 Week Low
$26.43
$1.05
52 Week High
$36.05
$4.98

Technical Indicators

Market Signals
Indicator
BHB
ADCT
Relative Strength Index (RSI) 49.83 48.69
Support Level $28.38 $3.79
Resistance Level $32.60 $4.77
Average True Range (ATR) 0.96 0.26
MACD 0.12 -0.05
Stochastic Oscillator 87.44 19.74

Price Performance

Historical Comparison
BHB
ADCT

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: